Heartflow, Inc. Cost of Revenue
Heartflow, Inc. (HTFL) reported Cost of Revenue of $10.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- Heartflow, Inc. cost of revenue for the quarter ending 2026-06-30 was $10.89M, a 2.31% increase year-over-year.
- Heartflow, Inc. cost of revenue for the quarter ending 2026-03-31 was $10.42M, a 12.51% increase year-over-year.
- Heartflow, Inc. cost of revenue for the quarter ending 2025-12-31 was $10.07M, a 15.35% increase year-over-year.
- Heartflow, Inc. cost of revenue for the quarter ending 2025-09-30 was $10.86M, a 35.81% increase year-over-year.
- Heartflow, Inc. cost of revenue for fiscal 2025 was $40.84M, a 30.22% increase from fiscal 2024.
- Heartflow, Inc. cost of revenue for fiscal 2024 was $31.36M, a 7.68% increase from fiscal 2023.
- Heartflow, Inc. cost of revenue for fiscal 2023 was $29.12M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.89M 10-Q · filed 2026-08-13 | $21.32M 10-Q · filed 2026-08-13 | $31.38M derived: sum of 3 quarters · filed 2026-08-13 | $42.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $10.42M 10-Q · filed 2026-05-14 | $20.49M derived: sum of 2 quarters · filed 2026-05-14 | $31.35M derived: sum of 3 quarters · filed 2026-05-14 | $42.00M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $10.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $20.93M derived: sum of 2 quarters · filed 2026-03-18 | $31.57M derived: sum of 3 quarters · filed 2026-08-13 | $40.84M 10-K · filed 2026-03-18 |
| 2025-09-30 | $10.86M 10-Q · filed 2025-11-12 | $21.51M derived: sum of 2 quarters · filed 2026-08-13 | $30.77M 10-Q · filed 2025-11-12 | $39.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.65M 10-Q · filed 2026-08-13 | $19.91M 10-Q · filed 2026-08-13 | $28.64M derived: sum of 3 quarters · filed 2026-08-13 | $36.63M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $9.26M 10-Q · filed 2026-05-14 | $17.99M derived: sum of 2 quarters · filed 2026-05-14 | $25.99M derived: sum of 3 quarters · filed 2026-05-14 | $33.20M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $16.72M derived: sum of 2 quarters · filed 2026-03-18 | $23.94M derived: sum of 3 quarters · filed 2026-03-18 | $31.36M 10-K · filed 2026-03-18 |
| 2024-09-30 | $8.00M 10-Q · filed 2025-11-12 | $15.21M derived: sum of 2 quarters · filed 2025-11-12 | $22.63M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $7.21M 10-Q · filed 2025-09-19 | $14.63M 10-Q · filed 2025-09-19 | ||
| 2023-12-31 | $29.12M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |